Recombinant human butyrylcholinesterase in complex with 1-(cyclohexylmethyl)-5-(2,4-difluorobenzyl)-N-(2-(dimethylamino)ethyl)-1H-indazole-6-carboxamide

Recombinant human butyrylcholinesterase in complex with 1-(cyclohexylmethyl)-5-(2,4-difluorobenzyl)-N-(2-(dimethylamino)ethyl)-1H-indazole-6-carboxamide Descriptor: 1-(cyclohexylmethyl)-5-[(2,4-difluorophenyl)methyl]-N-[2-(dimethylamino)ethyl]-1H-indazole-6-carboxamide, 2-(N-MORPHOLINO)-ETHANESULFONIC ACID, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... Authors: Brazzolotto, X, Ferjancic Benetik, S, Knez, D, Proj, M, Gobec, S, Nachon, F. Deposit date: 2025-01-28 Release date: 2025-08-20 Last modified: 2025-09-10 Method: X-RAY DIFFRACTION (2.66 Å) Cite: Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38 alpha Mitogen-Activated Protein Kinase Inhibitors. J.Med.Chem., 68, 2025

重组人丁酰胆碱酯酶（recombinant human butyrylcholinesterase）与1-(环己基甲基)-5-(2,4-二氟苄基)-N-(2-(二甲氨基)乙基)-1H-吲唑-6-甲酰胺的复合物
描述项：1-(环己基甲基)-5-[(2,4-二氟苯基)甲基]-N-[2-(二甲氨基)乙基]-1H-吲唑-6-甲酰胺、2-(N-吗啉代)乙磺酸（2-(N-MORPHOLINO)-ETHANESULFONIC ACID）、2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖（2-acetamido-2-deoxy-beta-D-glucopyranose）等
作者：Brazzolotto X、Ferjancic Benetik S、Knez D、Proj M、Gobec S、Nachon F
入库日期：2025-01-28
发布日期：2025-08-20
最后修改日期：2025-09-10
实验方法：X射线衍射（X-RAY DIFFRACTION），分辨率2.66埃（2.66 Å）
引用文献：《靶向神经炎症与认知衰退：首款兼具丁酰胆碱酯酶与p38α丝裂原活化蛋白激酶双重抑制活性的首创型（First-in-Class）化合物》，《Journal of Medicinal Chemistry》（J. Med. Chem.），第68卷，2025年